Pharmaceutical company Karo Healthcare set to seize Perrigo's €120 million skin care venture following KKR takeover.

Karo Healthcare, a leading player in the European consumer healthcare market, has announced its acquisition of Perrigo's Dermacosmetics portfolio. This transaction, expected to close in Q1 2026, marks a significant transformational step for Karo Healthcare towards becoming a multi-channel European consumer healthcare leader.

The acquired portfolio includes some of the leading skin health brands such as ACO, Biodermal, Emolium, and Iwostin. These brands boast strong brand recognition and endorsements from healthcare professionals, providing an entry platform into Poland, one of the region's fastest-growing consumer health markets.

Hans Arstad, Managing Director at KKR, expressed optimism about the future success of the businesses, brands, and employees following the acquisition. Karo Healthcare's CEO, Christoffer Lorenzen, stated that the acquisition brings "attractive, science-backed, and trusted skin health brands" to the company.

KKR, known for its history of successful corporate carve-outs, will reportedly benefit the businesses and employees involved in the acquisition. Alvarez & Marsal was responsible for advising on the integration process following the acquisition, while Morgan Stanley acted as the financial advisor to Karo Healthcare during the acquisition process.

Legal counsel for Karo Healthcare was provided by Kirkland & Ellis, Simpson Thacher & Bartlett, and White & Case. PwC advised on the financial due diligence for the acquisition.

Following the completion of the acquisition, Karo Healthcare looks forward to welcoming new employees. The deal will add over €120m in annual revenues across the Nordics, Netherlands, and Poland, strengthening Karo Healthcare's core presence in Northern Europe.

CEO Christoffer Lorenzen expressed his excitement about the acquisition, stating, "We are delighted to bring these attractive, science-backed, and trusted skin health brands into the Karo Healthcare family. This acquisition is a significant step in our journey towards becoming a leading multi-channel European consumer healthcare company."

While the exact names of the leadership involved in the merger were not disclosed, the acquisition is set to be a game-changer for Karo Healthcare, positioning the company for continued growth and success in the European consumer healthcare market.